It is a heterogeneous disease classified into various molecular subtypes, such as luminal A breast cancer, luminal B breast cancer, HER2-enriched breast cancer, and triple-negative breast cancer (TNBC) [3]. The gene discussed is ERBB2; the disease is breast cancer.